| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DMAC | Voting Common Shares, no par value per share | Purchase | $21.6K | +18.1K | +16.44% | $1.19 | 128K | Nov 29, 2022 | Direct | F1, F2 |
| transaction | DMAC | Voting Common Shares, no par value per share | Purchase | $3.53K | +2.97K | +2.31% | $1.19 | 131K | Nov 30, 2022 | Direct | F1, F2 |
| transaction | DMAC | Voting Common Shares, no par value per share | Purchase | $55.4K | +46.1K | +35.13% | $1.20 | 177K | Dec 1, 2022 | Direct | F2, F3 |
| holding | DMAC | Voting Common Shares, no par value per share | 25.6K | Nov 29, 2022 | See footnote | F4 | |||||
| holding | DMAC | Voting Common Shares, no par value per share | 21.1K | Nov 29, 2022 | By Spouse | ||||||
| holding | DMAC | Voting Common Shares, no par value per share | 54.2K | Nov 29, 2022 | By Children |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.19, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. |
| F2 | Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,118 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.20, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4. |
| F4 | These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power. |